Kings Path Partners »

Adma Biologics shares owned by Kings Path Partners

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Kings Path Partners from 13F filings

Historical chart of Kings Path Partners investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Kings Path Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Kings Path Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $527k 29k 18.21
2025-03-31 $425k 21k 19.84

More positions owned by Kings Path Partners

Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Global Core Plus (DFGP)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Malvern Fds Core Bd Etf (VCRB)

View all positions for Kings Path Partners

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Westfield Capital Management Company
Capital Research Global Investors
Nuveen
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
UBS Group
Thrivent Financial for Lutherans
Citadel Advisors
Caligan Partners

View all funds holding Adma Biologics